NDC 70518-2909-2 - Carbidopa and levodopa
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-2909
- Requested NDC
- 70518-2909-2
- Package NDCs from labels
- 70518-2909-0, 70518-2909-2, 70518-2909-1
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2024-09-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Carbidopa and Levodopa Tablets, USP | REMEDYREPACK INC. | 2024-09-20 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70518-2909-0 | 2022-02-09 | C162847 | 48780-1 | d6a99b39-7cff-a426-e053-dadaa90af4c2 | Carbidopa and Levodopa Tablets, USP |
| 70518-2909-0 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-7cff-a426-e053-dadaa90af4c2 | Carbidopa and Levodopa Tablets, USP |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Bryant Ranch Prepack | 998f805d-da97-484e-a931-e409e8b8c65a | 2025-04-07 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| YVTYVT MICRODERMABRASION FACIAL SCRUB | YVTYVT MICRODERMABRASION FACIAL SCRUB | Beijing JUNGE Technology Co., Ltd. | 2f30fc45-42e2-c766-e063-6394a90a8d68 | 2025-02-28 | Warnings | OP1R32D61U |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Coupler LLC | 2d9469ba-02b2-0cfc-e063-6394a90a6292 | 2025-02-07 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa-levodopa | CARBIDOPA AND LEVODOPA | Coupler LLC | 2cdca970-f077-3a80-e063-6294a90ab335 | 2025-01-29 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | A-S Medication Solutions | ea1dd532-9fb3-47c2-863c-b288ca7bb24e | 2025-01-22 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | A-S Medication Solutions | 739b2f8d-8b5c-4b57-b5d4-5e6429c7c1ed | 2025-01-22 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | NCS HealthCare of KY, LLC dba Vangard Labs | 45909de3-0852-4e61-8a9e-23f8fcc2463a | 2024-12-06 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| CARBIDOPA | CARBIDOPA | Zydus Lifesciences Limited | 83012ccc-aba2-45bb-9326-dc30cdeb4e3b | 2024-11-26 | MNX7R8C5VO | |
| Focus Spectrum HP | GABA (GAMMA-AMINOBUTYRIC ACID), L-DOPA, NOREPINEPHRINE (BITARTRATE), SEROTONIN (HYDROCHLORIDE), ADRENOCORTICOTROPHIN, ANACARDIUM ORIENTALE, ARSENICUM ALBUM, BARYTA CARBONICA, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, HYOSCYAMUS NIGER, LYCOPODIUM CLAVATUM, STRAMONIUM | Engergique, Inc. | c21bdb69-aaad-4095-bd89-eb1fe658271f | 2024-10-24 | Warnings | 46627O600J |
| L DOPA 4X | L DOPA | BioActive Nutritional, Inc. | 595b2d31-db9e-4eec-984f-92e93b274b3b | 2024-10-17 | Warnings | 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | A-S Medication Solutions | f207467e-ac62-446a-b42e-371efd0c7b2b | 2024-10-16 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | A-S Medication Solutions | 7219022c-a56a-4501-9437-601f6cb34e6b | 2024-10-16 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Spectric | AGARICUS MUSCARIUS, ASPARTAME, BUFO RANA, CARCINOSIN, CEREBRUM SUIS, ETHYLICUM, HELLEBORUS NIGER, HYDROGEN, HYOSCYAMUS NIGER, KALI BROMATUM, L-DOPA, NEON, OLIBANUM (BOSWELLIA SERRATA), PLACENTA TOTALIS SUIS, SEROTONIN (HYDROCHLORIDE), STRAMONIUM, THUJA OCCIDENTALIS | Deseret Biologicals, Inc | 4ee7f979-c30d-4062-a453-27b6b0b38247 | 2024-09-23 | Warnings | 46627O600J |
| 228d7ca5-da4d-a904-e063-6394a90a445c | 67d21425-fa49-405e-ac3d-327667e921b5 | 2024-09-20 | Warnings, Adverse reactions | 228d7ca5-da4d-a904-e063-6394a90a445c 67d21425-fa49-405e-ac3d-327667e921b5 | ||
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | NCS HealthCare of KY, LLC dba Vangard Labs | ef0be743-e6f3-4662-8b0c-53f1eda4638a | 2024-09-13 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Spectric | ETHYLICUM, KALI BROMATUM, ASPARTAME, L-DOPA, SEROTONIN (HYDROCHLORIDE), CEREBRUM SUIS, PLACENTA TOTALIS SUIS, AGARICUS MUSCARIUS, BUFO RANA, HELLEBORUS NIGER, HYOSCYAMUS NIGER, OLIBANUM (BOSWELLIA SERRATA), STRAMONIUM, THUJA OCCIDENTALIS, HELIUM, NEON, CARCINOSIN, HYDROGEN | Deseret Biologicals, Inc | d1981aca-de84-404d-8d38-3a013a531426 | 2024-09-11 | Warnings | 46627O600J |
| Multi-Phenolic | MANNOSE, 5-HYDROXYTRYPTOPHAN, ACETALDEHYDE, ACETYLCHOLINE CHLORIDE, ASCORBICUM ACIDUM, ASPARTAME, BUTYLATED HYDROXYTOLUENE, CAFFEIC ACID, CANDIDA ALBICANS, CINNAMIC ACID, CONIFERYL ALCOHOL, COUMARINUM, DOPAMINE HYDROCHLORIDE, ESTRADIOL, GABA (GAMMA-AMINOBUTYRIC ACID), GALLICUM ACIDUM, HISTAMINUM HYDROCHLORICUM, HYDROCORTISONE, INDOLUM, L-DOPA, L-PHENYLALANINE, MELATONIN, MENADIONE, NOREPINEPHRINE (BITARTRATE), PETROSELINUM CRISPUM, PHENYL ISOTHIOCYANATE, PIPERINE, PROGESTERONE, PYRROLE, QUERCETIN, | Energique, Inc. | 492b412a-01cc-48f2-bcdc-6fffcc651963 | 2024-08-23 | Warnings | 46627O600J |
| CARBIDOPA AND LEVODOPA | CARBIDOPA AND LEVODOPA | NuCare Pharmaceuticals,Inc. | ad2ab0c4-188b-f025-e053-2a95a90a2816 | 2024-07-17 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | A-S Medication Solutions | 84831a49-02d8-421e-8f05-f1358d7149cb | 2024-06-28 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| L-Dopa | L-DOPA | Deseret Biologicals, Inc. | ded984ce-b8d1-40a0-b5ef-a5f528955332 | 2024-04-15 | Warnings | 46627O600J |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.